Short Interest in Novozymes A/S (OTCMKTS:NVZMY) Increases By 1,180.5%

Key Points

• Short interest in Novozymes A/S increased by 1,180.5% in August, rising from 4,100 to 52,500 shares, although only 0.0% of the company's stock is currently sold short.
• The company recently announced a dividend payment of $0.1856 per share, with a scheduled payout on September 11th, which represents a yield of 88.0%.
• Wall Street analysts have mixed views on the stock, with ratings ranging from a "Strong Buy" to a "Sell," resulting in an average rating of "Moderate Buy."

Novozymes A/S (OTCMKTS:NVZMY - Get Free Report) was the target of a large increase in short interest in August. As of August 31st, there was short interest totaling 52,500 shares, an increase of 1,180.5% from the August 15th total of 4,100 shares. Currently, 0.0% of the company's stock are sold short. Based on an average daily volume of 148,700 shares, the days-to-cover ratio is currently 0.4 days. Based on an average daily volume of 148,700 shares, the days-to-cover ratio is currently 0.4 days. Currently, 0.0% of the company's stock are sold short.

Novozymes A/S Stock Performance

Shares of NVZMY traded down $0.13 during trading hours on Thursday, reaching $63.25. 16,283 shares of the company traded hands, compared to its average volume of 40,263. The stock has a market capitalization of $29.62 billion, a P/E ratio of 40.03, a P/E/G ratio of 1.25 and a beta of 0.93. Novozymes A/S has a 12-month low of $53.95 and a 12-month high of $75.99. The business has a fifty day moving average price of $66.67 and a 200-day moving average price of $65.52. The company has a quick ratio of 1.07, a current ratio of 1.75 and a debt-to-equity ratio of 0.28.

Novozymes A/S Cuts Dividend

The business also recently declared a dividend, which will be paid on Thursday, September 11th. Investors of record on Wednesday, September 3rd will be given a dividend of $0.1856 per share. The ex-dividend date of this dividend is Tuesday, September 2nd. This represents a yield of 88.0%. Novozymes A/S's payout ratio is 23.42%.

Wall Street Analysts Forecast Growth

Separately, Zacks Research downgraded shares of Novozymes A/S from a "strong-buy" rating to a "hold" rating in a research report on Monday, August 25th. Two research analysts have rated the stock with a Strong Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock has an average rating of "Moderate Buy".

Novozymes A/S Company Profile

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.